Compass Financial Group (South Dakota)’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$359K Buy
1,429
+1
+0.1% +$215 0.04% 78
2026
Q1
$311K Buy
1,428
+435
+44% +$96.5K 0.04% 80
2025
Q4
$227K Buy
993
+1
+0.1% +$228 0.03% 94
2025
Q3
$230K Buy
+992
New +$202K 0.03% 94
2025
Q2
Sell
-970
Closed -$203K 100
2025
Q1
$203K Buy
+970
New +$189K 0.04% 90

Other funds holding ABBV

Compass Financial Group (South Dakota)'s ABBV Position: Q2 2026 in Review

Compass Financial Group (South Dakota) increased its AbbVie (ABBV) stake by 0.07% in Q2 2026, buying an estimated $215 and bringing the position to 1,429 shares worth $359K. The position accounts for 0.04% of the portfolio, ranked #78.

Compass Financial Group (South Dakota) first reported a position in ABBV in Q1 2025 and has held it in 5 quarters since. 2,422 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Compass Financial Group (South Dakota) held 1,429 shares of AbbVie worth $359K as of Q2 2026.
  • Compass Financial Group (South Dakota) bought 1 AbbVie share in Q2 2026, an estimated $215.
  • AbbVie made up 0.04% of Compass Financial Group (South Dakota)'s portfolio in Q2 2026, its #78 holding.
  • Compass Financial Group (South Dakota) first reported a position in AbbVie in Q1 2025 and has held it in 5 quarters since.
  • 2,422 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Compass Financial Group (South Dakota)'s 13F filing for Q2 2026, filed 5 Aug 2026.